2025 Fellows Courses

Targeting Inflammation in Atherosclerotic Disease: A Case-Based Discussion

Sponsored by SCAI. Supported by Novo Nordisk.
Introductory Remarks
Case Presentation
Manasi Tannu, Duke Clinical Research Institute, Durham, NC
What Are Currently Available Strategies to Reduce Inflammatory Risk?
Binita Shah, MD, MS, FSCAI, NYU Grossman School of Medicine, New York, NY
Novel Therapies for Targeting Inflammation in ASCVD
Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC